Delivery Order SPE2DB22D1202-SPE2DB24FVDV0
Award Date
6/17/24
Potential Completion Date
6/18/24
Potential Value
$2.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML. The contract, valued at $3,011.63, was awarded on June 4, 2024 by the Defense Logistics Agency (DLA) with a completion date of June 5, 2024. It is a firm fixed-price delivery order contract. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) for the delivery of the pharmaceutical product ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML. The contract has a ceiling value of $2,171.19 and a period of performance through July 11, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of ACTEMRA 80 MG/4 ML VIAL 4ML, a pharmaceutical product. The single-award contract, valued at $2,036.66, was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), on June 6, 2024 with a completion date of June 7, 2024. Amerisourcebergen, as a major pharmaceutical distribution company, holds a significant Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,513,924 units of the pharmaceutical product ACTEMRA 400 MG/20 ML VIAL 20ML. The $1,560.34 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, on May 6, 2024 with a completion date of May 7, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a single-award Indefinite Delivery Contract (IDC) valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $5,757.04 firm fixed-price delivery order is for the supply of the pharmaceutical product Actemra 162 mg/0.9 ml syringe. The award does not have a set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle to...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty medication, with a ceiling value of $23,327.91 and a completion date of July 23, 2024. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,843.19 firm fixed price delivery order contract covers the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty medication. The contract has an ultimate completion date of March 18, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,630.88 Delivery Order is for the pharmaceutical product ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML. This order is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $58,289.33, is a delivery order for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty medication. The contract has an ultimate completion date of March 26, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, to supply Actemra Actpen 162 mg/0.9 ml drug vials. The $15,530.73 Firm Fixed Price delivery order contract has an ultimate completion date of August 29, 2024. Amerisourcebergen, through its Corporate Office division, provides a wide range of pharmaceutical and medical supplies to various government agencies and healthcare programs, including...